Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglustat and Trehalose (BBDF-1) in CLN3 Batten Disease
NCT05174039Phase 2Completed
- Sponsor
- Beyond Batten Disease Foundation
- Start
- Mar 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miglustat in CLN3 disease (CLN3), sponsored by Beyond Batten Disease Foundation. Started Mar 2022; status: completed.
02
Drugs
miglustat
03
Conditions
CLN3 disease (CLN3)
Beyond the preview
Go deeper on NCT05174039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05174039.